Kaiser Bottom Fish OnlineFree trialNew StuffHow It WorksContact UsTerms of UseHome
Specializing in Canadian Stocks
SearchAdvanced Search
Welcome Guest User   (more...)
Home / Research Tools
Research Tools
 Corporate Profile: Diagnos Inc
    Publisher: Kaiser Research Online
    Author: Copyright 2013 John A Kaiser

 
Diagnos Inc (ADK-V)
Trade DateVolumeHighLowCloseChgStatus
March 27, 202498,800$0.25$0.23$0.24($0.02)Trading
KRO Profile - Members OnlyCorporate Web Site Not AvailableTreeExchQuote
Issued
21,293,126
Price
$0.235
Working Capital
($689,990)
Key People: Andre Larente (Pres), Marc-Andre Massue (CFO), Michel Fontaine (VP CD),
Diluted
27,061,394
Insiders
15.7%
As of
12/31/2018
Company supplied Corporate Overview - not available
The free corporate profile serves as a fast gateway for KRO members via the map cards to resources such as the KRO Profile which includes financial, insider and project details as well as news releases and KRO comments for which headline links are provided below. Links to the company's web site and project web pages are available within this free corporate profile if the company has a multi-user corporate membership (they are always available in full member only KRO Profile). A corporate membership provides the company with complete multiple user access to KRO resources and entitles the company to provide a corporate overview for the subject company's unrestricted corporate profile.
Company Related KRO Comments
Jan 13, 2015Spec Value Hunter Comment: Recommendation Strategy for Diagnos Inc
Sep 26, 2013Quick Note: Diagnos Inc (ADK-V)

Company News Releases - Members Only
Mar 22, 2024Closing of Second and Final Tranche of Private Placement
Mar 4, 2024Grant of Stock Options
Feb 29, 2024Welcomes Mr. Michael Braeuel to its Board of Directors
Feb 27, 2024Closing of First Tranche of Private Placement
Feb 23, 2024Variation in One Insider Ownership of Common Shares
Feb 21, 2024Recognized as a Top TSX Venture Exchange Company
Jan 16, 2024Appoints New Chief Operating Officer
Dec 11, 2023BULLETIN V2023 0221; Resume Trading
Dec 11, 2023Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica, a Global Leader in Vision Care
Dec 7, 2023Private Placement Non Brokered
Dec 4, 2023Closing of Private Placement
Oct 5, 2023AI Retina Analysis is being deployed across Canadas Largest Specialist Care Provider in Diabetes & Endocrinology
May 26, 2023Private Placement non brokered, Convertible Debentures
May 18, 2023Closing of Private Placement and Exercise of Stock Warrants
May 17, 2023DIAGNOS and IRIS, The Visual Group Strengthen Partnership with the Launch of IRIS ai Powered by DIAGNOS
Feb 28, 2023DIAGNOS and ETS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts
Feb 14, 2023DIAGNOS and ETS to Present Ground breaking Research on Mass Screening for Macular Edema at ARVO 2023
Feb 10, 2023Grant of Stock Options
Jan 31, 2023Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals
Jan 25, 2023Private Placement non brokered, Convertible Debentures
Jan 13, 2023Closing of Private Placement
Dec 21, 2022Private Placement non brokered, Convertible Debentures
Dec 15, 2022Provides Additional Information to the Closing of Private Placement
Dec 12, 2022Closing of Private Placement
Nov 25, 2022Closing of Private Placement
Oct 27, 2022Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
Sep 1, 2022Closing of Private Placement
Aug 18, 2022Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
Jul 27, 2022Continues Expansion in Canada with Kick off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics
Jun 23, 2022Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance
Jun 7, 2022Deployment of its Age Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group
May 26, 2022DIAGNOS and the CHUM are Launching the Testing Phase of Autonomous Artificial Intelligence Solutions Dedicated to Diabetic Retinopathy Screening
May 10, 2022a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico
Apr 26, 2022The Extension of its Contract with Novo Nordisk for the Follow up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio
Mar 30, 2022Private Placement non brokered, Convertible Debenture
Mar 28, 2022Closing of Private Placement and New Marketing Director
Mar 15, 2022CAN Health Network and Quebec Based DIAGNOS Announce Life Changing Diabetic Retinopathy Screening Program Partnership
Mar 1, 2022Closing of Private Placement
Feb 10, 2022Successfully Completes ISO / MDSAP Audit
Jan 26, 2022Provides Corporate Update for 2021 and Outlook for 2022
Nov 23, 2021Will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA STROKE.
Oct 28, 2021Delivers World Class Results in the MICCAI2021 Contest: GAMMA
Sep 16, 2021A Multi Year Contract with Juarez Health & Medical Tourism Cluster
Sep 14, 20213 Year Contract with Cielo Vista Eye Clinic in Mexico
Sep 10, 2021Voting Results of Annual Meeting of Shareholders
Sep 2, 2021Three Year Contract Renewal with Optina Diagnostics Providing a Telemedicine Platform to Support their Early Detection of Alzheimer's Disease Test
Aug 17, 2021Date of Annual General and Special Meeting of Shareholders
Aug 16, 2021Signs Memorandum of Understanding with Essilor International.
Aug 5, 2021A.I. retinal screening technology expands into international markets
Jul 28, 2021A Pilot with Opticalia in Spain
Jul 22, 2021The Official Opening of the AI Assisted Screening Clinic at Magrabi Hospital with the Presence of the Undersecretary of the Ministry of Health of Saudi Arabia
Jul 20, 2021Initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA STROKE
Jun 15, 2021A Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Jun 9, 2021IRIS teams up with DIAGNOS in a multi year agreement to implement Artificial Intelligence technology with support from the INVEST AI Program
Apr 6, 2021Enters into an Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
Mar 9, 2021Following a successful Proof of Concept (POC) pilot study, is finalising its new application CARA STROKE to address Stroke prevention and management, a market estimated at $36 Billion
Mar 4, 2021Third Largest Optical Retailer in Costa Rica Piloting CARA and its Telemedicine technology
Mar 3, 2021Stock Options Grants
Feb 26, 2021Exercise Of Stock Warrants And Provides A Cash Update
Feb 24, 2021Its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and
Feb 2, 2021Further Deployment of its AI based CARA Technology in Saudi Arabia
Jan 28, 2021The Re Opening of its Medical Testing in Panama
Jan 21, 2021Successfully Completes ISO 13485 / MDSAP Audit
Jan 19, 2021A 3 year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence
Jan 14, 2021Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients
Jan 5, 2021Provides Market Activity Update
Nov 12, 2020The Resumption of Screening Operations in Saudi Arabia and Conveys Congratulations to Dr. Salman Abdullah Al Mutairi for his Assignment as Secretary General of the Council of Private
Nov 5, 20209071 8776 Quebec Inc. Acquires Further Interest in DIAGNOS Inc.
Oct 8, 2020Warrant Term Extension
Oct 7, 2020Stock Warrants Term Extension
Oct 6, 2020Mexico's Largest Optical Retailer to Use DIAGNOS' AI Technology to Detect Early Stage Blindness
Sep 28, 2020Welcomes Mr. Vincent Duhamel and Mr. Robert J. Dunn to its Board of Directors
Sep 15, 2020A Multi Year Contract with Chaparral Medical Group in California
Sep 8, 2020Receives $2,000,000 Assistance from Quebec
Aug 26, 2020Annual General Meeting of Shareholders Date and Attendance Special Measures
Jul 14, 2020Signing of Service Agreement with the Colombian Telemedicine Centre
Jul 7, 2020Client in California, the Chaparral Medical Group of Clinics, is Reopening the Screening Services for Diabetic Retinopathy after the COVID 19 Shutdown
Jun 3, 2020Signing of Strategic Partnership Agreement with Labtician Ophthalmics, Leading Global Ophthalmology Product and Equipment Supplier
Apr 27, 2020Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program
Mar 27, 2020Stock Options Grant
Mar 25, 2020Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the 'US White House Call to Action' to Analyse and Transform COVID 19 Data into Clinical Knowledge
Mar 11, 2020Private Placement Non Brokered
Mar 9, 2020Closing of Oversubscribed $2.1 Million Private Placement
Feb 19, 2020Shares for Debt
Feb 14, 2020Shares for Debt Transaction
Jan 14, 2020Successfully Completes ISO 13485 / MDSAP Surveillance Audit
Jan 7, 2020AI based clinical Eye Test for Diabetic Retinopathy Demonstrates Exceptional Performance at the CHUM, expands for an Additional Six Months
Dec 12, 2019A New Strategic Partnership Agreement in Costa Rica
Dec 10, 2019Collaborative Agreement in the North American Borderplex Region
Nov 28, 2019Welcomes Mr. Francis Bellido to its Board of Directors
Nov 26, 2019Short Term Financing
Oct 29, 2019Local Partner Selected Following a Competitive Bid from the Mexican Government
Sep 25, 2019Appoints New Chairman of the Board of Directors
Sep 20, 2019Voting Results of Annual Meeting of Shareholders
Sep 16, 2019Closing of a Private Placement
Sep 13, 2019Private Placement
Sep 10, 2019Receives Medical Device Marketing Authorization from the Saudi Food and Drug Authority to commercialize CARA in Saudi Arabia
Sep 3, 2019An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM
Jun 20, 2019An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM
Jun 18, 2019Welcomes Mr. Francois Cote to its Board of Directors
Jun 17, 2019Short Term Financing
Jun 10, 2019Corporate Reorganization Update
Jun 6, 2019HIPAA Compliance for the US Market
Jun 4, 2019The Appointment Of Mr. Riadh Kobbi As Vice President Business Intelligence
May 30, 2019Opening Of Two New Screening Clinics In Hafar Al Batin, To Screen 10,000 Patients In The Next Six Months With Its Partner Kanhoor Medical Co.
May 28, 2019Adds a Second Screening Site at the CHUM in the Ophthalmology Department
May 15, 2019Completes Redemption of Convertible Debt
May 7, 2019Saudi FDA Filing for its CARA AI Platform
May 1, 2019Joins Forces with a Cannabis Based Medicinal Products Distributor
Apr 30, 2019Redeems Convertible Debt
Apr 23, 2019Successfully Completes ISO 13485:2016 MDSAP Audit
Apr 16, 2019Will Supply Its Artificial Intelligence Technology to the First Hypertensive Retina Screening Clinic in Saudi Arabia.
Apr 10, 2019Approval of Corporate Reorganization
Apr 2, 2019New Contract with Government in Bangladesh Through its Partner Eyes for All
Mar 27, 2019An Update to the News Release Issued Earlier Today
Mar 27, 2019Memorandum of Understanding with one of the 5 largest hospitals in the US for the final development of its CARDIO application
Mar 13, 2019New Agreement in the United Arab Emirates with one of the Largest Pharmaceutical Companies in the World
Jan 29, 2019Welcomes Dr. Jean Francois Yale to the Board of Directors
Jan 22, 2019An Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM
Dec 4, 2018Collaboration with TS on Automated detection and grading of Diabetic Retinopathy using Deep Convolutional Neural Networks, (CNN) a new generation of Deep Learning Technique
Nov 21, 2018Enters into a Shares for Debt Transaction
Nov 13, 2018Addition of a Strategic Partner in the Country of Mexico
Nov 9, 2018Closing of Private Placement
Nov 6, 2018Private Placement of Common Stocks and Stock Warrants
Nov 1, 2018Closing of Private Placement of Common Stocks and Stock Warrants
Oct 24, 2018Private Placement Of Common Stocks And Stock Warrants & Shares For Debt
Sep 18, 2018To Provide Retinal Image Analysis using its AI Technology to 20/20NOW, the Leading Ocular Telehealth Provider in the United States
Sep 11, 2018Closing Of Private Placement Of Common Stocks And Stock Warrants
Sep 5, 2018Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease
Aug 24, 2018Private Placement of Common Stocks and Stock Warrants
Jul 31, 2018Update on Business Operations
Jul 10, 2018Installs its First Retina Screening Clinic based on Artificial Intelligence in Panama
Jul 5, 2018Closes Second and Final Tranche of Private Placement
Jul 4, 2018Broadens Collaboration With Government Of Mexico
Jun 29, 2018Provides Financing Updates
Jun 18, 2018Private Placement Non Brokered
Jun 14, 2018Hires Investor Relation Firm Momentum Public Relations and Provides Financing Update
Jun 12, 2018Availability Of New CARA High Blood Pressure Risk Assessment Based On FLAIRE Artificial Intelligence Platform
Jun 7, 2018Presents a Technological Showcase at the CHUM with the Opening of an Automated Diabetic Retinopathy Screening Clinic Assisted by AI (Artificial Intelligence) with Financial Support of the Quebec
May 28, 2018Private Placement And Stock Options Grant
Apr 6, 2018Diagnos Inc. Sells 10,500,000 Common Shares Of Albert Mining Inc.
Apr 4, 2018Welcomes Dr. Reid Maclellan to the Board of Directors
Mar 14, 2018The Opening of a Screening Clinic at Chaparral's Health Management Wellness Center for Medicare Beneficiaries
Mar 7, 2018Following a successful year, DIAGNOS Announces a One Year Agreement in United Arabs Emirates with a Major Pharmaceutical Company
Feb 27, 2018After Successful Screening Of 2,500 Patients As Part Of A Pilot Project With Kanhoor Medical Co, DIAGNOS Will Now Screen 35,000 patients In The Kingdom Of Saudi Arabia
Feb 14, 2018Provides A Market Update On Recent Trading
Feb 8, 2018Sells Shares in Diagnos Inc.
Jan 25, 2018Arrowhead Business And Investment Decisions Initiates Analyst Coverage Of DIAGNOS
Jan 17, 2018Next Release of its CARA Artificial Intelligence Platform Will Rely on Blockchain Technology for Security Control of Medical Records
Jan 10, 2018The Management of the Flagship Nuevo Yo Program by Novo Nordisk
Dec 19, 2017Successfully Passed ISO Annual Surveillance Audit
Dec 6, 2017Receives Support From Export Development Canada (EDC) For The Issuance Of A Performance Bond For The Issste Contract
Nov 29, 2017Hires Investor Relation Firm Arrowhead Business And Investment Decisions, Llc And Grants Stock Options
Nov 22, 2017A Second Contract For Its Cardio Platform With A Multinational Pharmaceutical Company And The Resignation Of A Director
Nov 9, 2017New Project With Cardiology Department Of The Centre National De Medecine Du Sport C.n.m.s Hospital Located In Alger, Algeria, Before Product Launch
Oct 24, 2017A One year Agreement In North Africa With A Major Pharmaceutical Company After Successful Pilot
Oct 23, 2017Private Placement Non Brokered, Convertible Debenture
Oct 23, 2017Closes Second Tranche Of Private Placement
Oct 17, 2017A New Partner In Cambodia, Garuda Health Services
Oct 16, 2017Closing Of A Private Placement
Sep 26, 2017Dtc Eligibility Of Its Common Shares In The Us
Sep 19, 2017Provides Timelines On Cardiovascular Disease (cvd) Prevention Test Development And Commercialization Plans
Aug 28, 2017Restatement Of March 31, 2017 Financial Statements Which Resulted In A Decrease In Expenses Of $2,491,096
Aug 22, 20172 Screening Clinics With Al Kahhal Medical Complex In The Kingdom Of Saudi Arabia
Aug 14, 2017Results From The Annual Meeting Of Shareholders, Appointments Of New Chairman And New Chief Medical Officer And Stock Options Grant
Jul 17, 2017Resume Trading
Jul 17, 2017Signs New Contract Valued At $ 4.16 Million USD (5.26 Million CAD) With The Government Of Mexico At ISSSTE To Screen And Monitor 320,000 Diabetics In 2017
Jul 5, 2017Successful Pilot At Chaparral Medical Group In California And A 3 Year Contract With The Opening Of A Second Eye Screening Clinic
Jun 27, 2017Receives Approval For Trading On The OTCQB Venture Market
Jun 12, 2017Amendment To Its Stock Option Plan
May 31, 2017New Mission In Healthcare After Its Divestiture From The Mining Industry
May 17, 2017Diagnos Acquires Interest In Majescor Resources Inc.
May 4, 2017Shares for Debt
May 4, 2017Private Placement Non Brokered, Convertible Debenture
Apr 28, 2017Private Placement Closing Update
Apr 27, 2017Closing Of Private Placement
Apr 24, 2017New Partnership In Bangladesh With Eyes For All
Apr 13, 2017Private Placement
Mar 15, 2017Diagnos, In A Strategic Move, Is Divesting Its Mining Division To Focus On Detection Of Critical Health Issues Through The Use Of Its Artificial Intelligence Platform
Feb 22, 2017Contract In The Kingdom Of Saudi Arabia With Alkanhoor Medical Co.
Feb 14, 2017Contract Extension With The Mexican Government And An Update For A Two year Potential National Coverage Program
Jan 26, 2017Nippon Dragon Resources Will Use Diagnos' Artificial Intelligence Tools To Optimize Exploration Of Its Rocmec1 And Denain Properties
Jan 24, 2017Successfully Completes A 2,000 Patient Pilot Project For The Mexican Social Security Institute
Jan 11, 2017Appoints New Director Mr. Georges Hebert
Jan 10, 2017Update On An Artificial Intelligence Digital Healthcare Solution Contract With Issste, An Organization Of The Mexican Government
Dec 21, 2016Monarques Gold Corp. Will Use Diagnos Artificial Intelligence Tools To Optimize Exploration Of Croinor Gold
Dec 13, 2016Successfully Passed Iso Certification Surveillance Audit
Dec 6, 2016Bayer Canada And Diagnos Join Efforts Against Diabetes
Dec 2, 2016Grants Stock Options
Nov 29, 2016Appoints New Director Dr. Netan Choudhry
Nov 21, 2016Diagnos Sells A Purchase Option To Majescor Resources For 131 Mining Claims Which Comprise 37 Kimberlite Targets Near The Renard Diamond Mine And Adamantin Project In Quebec
Nov 14, 2016A Pilot Project With The National Social Security System Of Mexico
Oct 25, 2016A New Pilot Contract In The South East Asia Region
Oct 18, 2016Two New Pilot Projects Contracts In North Africa
Oct 13, 2016Rights Offering Shares
Sep 26, 2016Appoints New Vice president And Grants Stock Options
Sep 14, 2016Closes Rights Offering For Gross Proceeds Of $1m
Sep 14, 2016Staked 131 New Property Claims Covering 37 Kimberlite Targets On The Same Areas As The New Diamond Renard Mine And Adamantin Project In Quebec
Sep 7, 2016Operational Update For A Project With A Mexican Government Organization
Sep 6, 2016Rights Expiry Delist
Aug 10, 2016Private Placement Non Brokered, Convertible Debenture
Jul 27, 2016Diagnos Announces: Majescor And Eastmain Resources Have Mobilized Teams To Start Its Prospecting Program On Diagnos Gold Targets In The Former Eastmain Mine Area (James Bay)
Jul 22, 2016Private Placement
Jul 21, 2016Rights Offering Shares
Jul 21, 2016Rights Offering
Jul 5, 2016Operational Update Of A Contract In India Valued At Up To $1.3m
Jun 13, 2016Shares for Bonuses
Jun 8, 2016Major Strategic Alliance In Latin America For A Contract Of $1.38 M Usd
Jun 7, 2016Short Term Financing
May 20, 2016Changes To Its Board Of Directors
May 19, 2016Private Placement Non Brokered, Convertible Debenture
May 18, 2016Update Following Closing Of Private Placement
May 4, 2016Shares for Bonuses
May 3, 2016Closing Of Private Placement
Apr 27, 2016Everton Acquires 136 Claims For Gold Targets Using Diagnos Cards System In Detour Lake Area, Quebec
Apr 25, 2016Short Term Financing
Apr 7, 2016Private Placement
Apr 4, 2016Shares for Bonuses
Mar 22, 2016Short Term Financing
Feb 26, 2016Financing Update
Jan 11, 2016Non brokered Private Placement
Jan 7, 2016Eloro Resources Issues Shares For Acquisition Of Geological Information Delivered Pursuant To A Services Agreement With Diagnos
Nov 18, 2015Bayer And Diagnos Join Efforts Against Diabetes
Sep 25, 2015Results From Annual Meeting Of Shareholders
Sep 23, 2015Provides General Business Update
Sep 1, 2015Closing Of Second Tranche Of Private Placement
Sep 1, 2015Private Placement Brokered, Convertible Debenture
Aug 28, 2015Amendment To Its Stock Option Plan
Jul 30, 2015Closes Private Placement Of Convertible Debentures
Jul 14, 2015Correction From Source: Diagnos Announces Impressive Results For The Automatic Detection Of Glaucoma Using Cara Algorithms
Jun 30, 2015Appoints New Executive Chairman & Announces Concurrent Private Placement
Jun 22, 2015Contract With Global Pharmaceutical Company In Mexico
Jun 16, 2015Industry Leading Performance Of Its Automated Dark Lesion Detection For Diabetic Retinopathy Screening
May 27, 2015A Strategic Alliance With The Largest Private Hospital Group In Latin America To Unburden Diabetes In The Public Health System
May 19, 2015Darc Chooses Cara For A Clinical Trial In Conjunction With A Top Five Pharmaceutical Company In The United States
May 4, 2015Licensing Deal With Inb Al Haythem Center In Algeria
Apr 14, 2015Licensing Deal With Clinique Hamouche In Algeria
Apr 10, 2015Retina Screening Project With Clinique Chifa Hydra In Algeria
Apr 1, 2015Review Of Cadillac Break Property Geophysics Yields Strong Targets
Mar 26, 2015Two Year Renewal Of Successful Program In The Uae
Mar 18, 2015First Screening Project In Poland With Globally Leading Pharmaceutical Company
Mar 10, 2015Contract With A Leading Ophthalmology Pharmaceutical Company In The USA
Mar 5, 2015Strategic Restructuring To Focus On Healthcare
Feb 17, 2015Pilot With A Major Public Health Institution In Mexico For Retinopathy Screening
Feb 12, 2015Opens Polish Subsidiary Diagnos Poland Sp. Z O.o.
Jan 21, 2015A Screening Program For Vision threatening Diseases (vtd) That Will Now Be Offered In Azur Retirement Residences Operated By The Cogir Management Corporation
Dec 11, 2014Alexandria Minerals Corporation Will Use Diagnos' Cards Technology For Its Cadillac Break Properties
Dec 3, 2014Diagnos And Puma Hit Again In The Turgeon South-Bern Zone In New Brunswick, Finding 2% Cu Over 6 Meters
Nov 25, 2014Opens Mexican Subsidiary Diagnos Internacional, S.a. De C.v.
Nov 19, 2014Resignation To The Board Of Directors
Oct 16, 2014The Opening Of A Clinical Retinopathy Screening Office In Algeria
Oct 2, 2014Healthcare's Commercialization Of Cara Passes $1m In Bookings
Sep 25, 2014Amendment To Its Stock Option Plan
Sep 16, 2014Contract With Dr. Kovil's Diabetes Care Centre In Mumbai
Sep 9, 2014Contract With Dr. Vishal Gupta's Diabetes And Endocrine Clinic In Mumbai
Sep 8, 2014Grant Of Stock Options
Sep 3, 2014First Retinopathy Screening Unit In Turkey
Aug 26, 2014First Retinopathy Screening Unit In Eastern Europe
Aug 21, 2014First Screening Unit In Argentina
Jul 24, 2014Changes To Its Board Of Directors
Jul 22, 2014Yet Another Expansion Of Successful Program In The UAE
Jul 16, 2014Signing Of Contract With Ministry Of Health Owned Medical Center In The United Arab Emirates
Jul 11, 2014Persistence Capital Partners Files Early Warning Report
Jul 10, 2014Property Asset or Share Purchase Agreement
Jul 10, 2014Declaration of Distribution
Jul 8, 2014Completes Merger With Warnex Inc. And Announces The Issuance Of Stock Warrants
Jun 27, 2014Shareholders Of Warnex Approve The Amalgamation With Diagnos
Jun 25, 2014Received TSX V Approval and Waives Due Diligence Condition to Amalgamation with Diagnos
Jun 2, 2014Warnex And Diagnos Enter into a Pre Amalgamation Agreement
May 6, 2014Final Closing Of Private Placement
May 5, 2014Warnex To merge with Diagnos
Apr 1, 2014Closing Of First Tranche Of Private Placement
Mar 11, 2014An Additional Expansion Of Successful Program In The Uae
Feb 25, 2014Private Placement
Feb 12, 2014Three Year Contract With First U.s. Based Primary Care Network, Chaparral Medical Group In California
Jan 13, 2014Healthcare (india) Pvt. Ltd. Announces The Signing Of A Letter Of Intent With Aditya Jyot A Leading Indian Ophthalmic Research And Treatment Eye Hospital
Dec 18, 2013Puma Exploration Samples 6.5% Copper On Diagnos Cards Generated Targets On The Southern Part Of The Turgeon Project In New Brunswick
Dec 17, 2013The Signing Of A Contract With A Major Pharma In India Following The Letter Of Intent Announcement In September 2013
Nov 26, 2013Contract Renewal And Expansion In The Uae
Oct 10, 2013Impressive Results For The Automatic Detection Of Age related Macular Degeneration Using Cara Algorithms
Sep 25, 2013Launches Manageo, A Turnkey, Web based Mining Claim Management Service
Sep 18, 2013The Creation Of Indian Subsidiary And The Opening Of An Office In India
Sep 11, 2013Completes $2.2 Million Exploration Mission Under Quebec's Plan Nord
Sep 5, 2013Grant Of Stock Options
Sep 4, 2013Signing Of A Letter Of Intent With A Major Global Pharma In India

 
 

You can return to the Top of this page


Copyright © 2024 Kaiser Research Online, All Rights Reserved